JENNIFER LOCKIE: Open Payments
NPI 1568228575 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 27 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $675 · 2025 $1,021
Education: $531Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $399 |
| Gilead Sciences, Inc. | 2 | $118 |
| SEAGEN INC. | 1 | $100 |
| Azurity Pharmaceuticals, Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Celgene Corporation | 2 | $38 |
| JAZZ PHARMACEUTICALS INC. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
Products named: VERZENIO, Trodelvy, VIVIMUSTA, ELAHERE, Nubeqa, REBLOZYL, ZEPZELCA, ALUNBRIG.
Industry payments across IL — which companies pay providers there.
